The HealthTechTAB (“TAB”) is an instrument sponsored by the EC funded project “NOBEL – Mobilising the European nano-biomedical ecosystem”, which has been designed as the prime initiative to support the translation of promising technologies for Heathcare in Europe. In this context, beneficiaries understand and acknowledge that the TAB service has to follow the rules and procedures of the EC funded project “NOBEL” (GA N° 766492).
The Management Unit and the experts of the TAB shall be responsible, foremost, for acting consistent with the TAB’s mission and Code of Conduct, and for promoting the best interests of beneficiaries who have formed a relationship with the TAB. The beneficiary interest principle requires serving the beneficiary interest by seeking to accomplish the objectives established by the understanding with the beneficiary while maintaining integrity and objectivity. Understanding with beneficiary requires establishing with the beneficiary a written or oral understanding about the responsibilities of the parties and the nature, scope, and limitations of services to be performed, and modify the understanding if circumstances require a significant change during the engagement.
The TAB shall act as dictated by the principles of objectivity and neutrality. Objectivity requires intellectual honesty and impartiality. Regardless of the particular service rendered, management staff and experts should protect the integrity of their work, maintain objectivity and avoid subordination of their judgement. Neutrality requires acting to the maximum of the self’s capacity without bias against any matter assigned to the TAB, and to deal with all stakeholders with neutrality and full equal
Staff and experts of the TAB shall provide services diligently. Diligence is the provision of services in a reasonably prompt and thorough manner, including the proper planning for, and supervision of, the rendering of professional services. Beneficiaries are also expected to be diligent in the fulfilment of their responsibilities and tasks related with the TAB support.
The TAB Management Unit and experts abide by strict confidentiality and conflicts of interest principles in interactions with the applications and projects supported. These principles apply for the entire service – related meetings and activities. Upon enrolment in the TAB experts are obliged to sign a service agreement with confidentiality and no conflict of interest clauses.
The TAB sessions, meetings and activities are identified as “privileged”. They are conducted with the understanding that experts are specifically assigned by the Management Unit for the review of sensitive information, and advisory and/or coaching of beneficiaries on a privileged basis. By agreeing to take part, experts in these activities agree to:
In the course of the TAB support intellectual property (copyrights, inventions, trademarks, etc.) may be developed. Experts acknowledge and agree that all intellectual property involved in the action (both background and foreground intellectual property) shall be solely and exclusively owned by beneficiaries.
TAB management staff, experts and beneficiaries acknowledge that they are serving and/or being sponsored by the public interest, and as such they shall agree to publish, promote and report all necessary information, provided it is not classified, for a transparent and accountable operation of the program, as needed and required by the European Commission rules and procedures.
All oral and written information, as documents, files and reports, regardless of whether they are for internal or external use, must contain accurate, true, reliable and authorised information. The obligation for integrity of information applies to the TAB staff, experts and beneficiaries.
None of the members of the TAB and of the “NOBEL” project warrants that any result or objective whether stated herein or not shall be achieved, be achievable or be obtained at all or by a given completion date or any other date. The TAB or any of the partners of “NOBEL” shall not be liable to the beneficiaries in contract, tort, negligence, breach of statutory duty or otherwise for any loss, damage, costs or expenses of any nature whatsoever incurred or suffered by beneficiaries of an indirect or consequential nature, including without limitation any economic loss or other loss of turnover, profits, business or goodwill.